Brief: China NT Pharma Establishes Formal Whistleblowing Policy
03/07/2026 16:58
BRIEF-China NT Pharma Establishes Formal Whistleblowing Policy July 3 (Reuters) - China NT Pharma Group Co Ltd 1011.HK:
ESTABLISHES FORMAL WHISTLEBLOWING POLICY APPROVED BY BOARD ON JULY 3, 2026
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY